ArticleJournal of pharmaceutical policy and practice2026
Antibiotic utilization pattern and its associated factors based on WHO AWaRe classification at a university hospital in the South of Thailand.
Article in Journal of pharmaceutical policy and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antibiotic overuse accelerates antimicrobial resistance (AMR), posing a major global health threat. The World Health Organization (WHO) AWaRe classification promotes rational antibiotic use, recommending that at least 60% of antibiotic consumption belongs to the Access group. This study evaluated antibiotic prescribing patterns and factors associated with Watch/Reserve antibiotic use in a Thai tertiary hospital. Methods: A cross-sectional study using longitudinal hospital databases (2021-2023) analyzed 28,892 antibiotic prescriptions from adult patients. Antibiotics were classified according to the 2023 WHO AWaRe framework. Antibiotic utilisation was quantified using Defined Daily Doses (DDDs), and generalised linear mixed-effects models were used to identify factors associated with Watch/Reserve versus Access antibiotic prescribing. Results: Access antibiotics remained the predominant prescribing category, accounting for 69.2%, 58.9%, and 61.8% of prescriptions in 2021, 2022, and 2023, respectively, while Reserve antibiotics accounted for <0.5% annually. Watch antibiotic utilisation increased over time and exceeded Access antibiotics among hospitalised Civil Servant Medical Benefit Scheme (CSMBS) beneficiaries in 2023. Female sex, older age, and higher Charlson Comorbidity Index were independently associated with Watch/Reserve prescribing. Universal Health Coverage (UHC) beneficiaries had significantly higher odds of receiving Watch/Reserve antibiotics. Conclusions: Although Access antibiotics predominated, increasing Watch antibiotic use highlights opportunities to strengthen hospital-wide antimicrobial stewardship. Routine AWaRe-based monitoring may facilitate benchmarking and promote more rational antibiotic prescribing across healthcare settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.